InsidersTradesSigma
Track the Heramed Limited stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, Heramed Limited has logged 3 public disclosures. Market capitalisation: €41.7m. The latest transaction was filed on 24 July 2026 (Sale). Among the most active insiders: Timothy Chapman. The full history is openly available.
3
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
2 ops.
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,065 of 28,836 companies
33.4
score / 100
Value17
Quality50
FCF yld-8.3%
Earn yld-9.4%
EV/EBITDA·
ROE-223%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2026
Declarations3 total
3,666,666 sharesShareASXISIN AU0000028367ASX:2924-03114023-2A1685796
5,267,720 sharesShareASXISIN AU0000028367ASX:2924-03107666-2A1682269
2,500,000 sharesShareASXISIN AU0000028367ASX:2924-03082745-2A1668366
3 of 3 declarations
About Heramed Limited
Heramed Limited is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance women's health.